Treatment News

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News


March 26, 2015
Even Very Early HIV Treatment May Not Reverse Damage to the Gut
HIV launches an immediate assault on the gut after infection, spurring inflammation and causing other damage that even very early antiretroviral treatment may not fully reverse.
March 25, 2015
Gilead Drug Shows Promise in Reversing HIV Latency
A so-called TLR7 agonist has shown promise in its ability to wake infected cells from a dormant, or latent, state and cause them to produce HIV.
March 24, 2015
Isentress and Protease Inhibitors Lead to Similar Fat Gains
People with HIV who start treatment with Truvada post similar fat gains whether they pair the tablet with Isentress or protease inhibitors.
March 23, 2015
Herpes Drug Valtrex (Valacyclovir) Found to Suppress HIV
The herpes drug Valtrex suppressed HIV in a small trial, raising the possibility it may one day be added to the HIV antiretroviral portfolio.
Sovaldi or Harvoni and Heart Med Cordarone Can Be a Fatal Mix
Nine people taking Harvoni or Sovaldi and the heart medication Cordarone (amiodarone) have suffered from low heartbeats; one died of a heart attack.
March 21, 2015
PrEP Is Ready for Primetime
New research underscores the great potential of Truvada as pre-exposure prophylaxis for preventing HIV among gay and bisexual men.
March 20, 2015
Quit-Smoking Drug Works Among People With HIV
The smoking cessation aid Chantix works about as well among people with HIV as those without, although less than a fifth of those taking the drug in a recent trial actually quit smoking.
March 19, 2015
More Poor Black Women Are Accessing Health Care, and Having Risky Sex
The proportion of poor African-American women accessing health care and HIV testing is rising in high AIDS prevalence areas.
March 18, 2015
World Health Organization Issues Hepatitis B Guidelines
The World Health Organization has issued its first hepatitis B guidelines, geared in particular toward simplifying treatment and care for those in limited-resource settings.
Update on the 'Mississippi Child,' Once Thought Cured of HIV
The clinicians responsible for caring for the “Mississippi Child,” who they once believed was cured of HIV, have published an update on her case in a letter to the New England Journal of Medicine.
March 17, 2015
Early HIV Phase May Be Less Infectious Than Once Thought
The acute, or very early, period of HIV infection may not be as infectious as prevailing wisdom has led scientists to believe.
March 16, 2015
Ocular Syphilis Outbreak Spreads Down West Coast, Blinding Two
After a cluster of ocular syphilis was identified in Washington State in late 2014, small outbreaks have occurred in San Francisco and now apparently Los Angeles.
March 13, 2015
FDA Approves Early Human Trial of Potential HIV Functional Cure
The U.S. Food and Drug Administration (FDA) has given the green light to an early human trial of an HIV gene therapy that may lead to a functional cure.
March 12, 2015
Europe OKs New, Highly Sensitive, Portable HIV Test From Alere
The Alere q HIV-1/2 Detect assay has received European regulatory approval—known as IVD CE marking.
March 11, 2015
People With HIV Have High Rates of Smoking, Low Rates of Quitting
HIV-positive Americans are more likely to smoke and less likely to quit smoking than the general population.
March 10, 2015
Single Dose of Selzentry Does Not Reach Levels High Enough for PrEP
Levels of Selzentry (maraviroc) in vaginal and rectal tissues following a single dose were not high enough to be effective as PrEP in a recent study.
March 09, 2015
Some Types of HIV Originated in West African Gorillas
Certain types of HIV appear to have originated in West African gorillas, and were likely transmitted to humans through bush meat hunting.
March 06, 2015
As PrEP Use in San Francisco Rises, Hope for Cutting HIV Rates
As PrEP use in San Francisco rises, researchers have projected that further increases could take a sizeable bite out of the city’s already falling HIV rate.
Several HIV Meds Steadily Raise Kidney Disease Risk Over Time
People with HIV who take Viread, Norvir, Reyataz or Norvir–boosted Kaletra are at increasing risk of kidney disease over time.
March 05, 2015
Delaying Hep C Therapy for HIV/HCV Coinfected People Is Risky
For those coinfected with HIV, waiting to begin hepatitis C treatment until liver damage progresses raises the risk of liver-related complications and death.
March 04, 2015
Low Rates of Viral Suppression Seen in South Africans With HIV
South Africa’s HIV-positive population has relatively low rates of engagement in health care and viral suppression, paralleling similarly low U.S. figures.
Newly HIV-Diagnosed New Yorkers Better Linked to Effective Care
New York City is better linking people diagnosed with HIV into prompt medical care, as well as getting them treated and to full viral suppression.
Coinfected People With Hep C May Have to Switch HIV Meds to Take Olysio
People who coinfected with HIV and hepatitis C  looking to take the HCV drug Olysio may need to change HIV medications to avoid drug-drug interactions.
March 03, 2015
Gay Mixed-HIV-Status Couple Study Has No Transmissions So Far
An ongoing study of gay mixed-HIV status couples has seen no transmissions within the couples at its interim two-year analysis.
96% Hep C Cure Rate for Harvoni in Those Coinfected With HIV
Harvoni yielded a 96 percent cure rate among people with genotype 1 of hepatitis C, as well as a small number of those with genotype 4.
Yet Another Study Touts the Benefits of Earlier HIV Treatment
Beginning HIV treatment when CD4s are higher than 500 significantly reduces the risk of major HIV-related illness and death when compared with delaying treatment.
March 02, 2015
WHO Calls for Universal Use of 'Smart Syringes' by 2020
The World Health Organization has called for all hospitals and clinics worldwide to use “smart syringes,” which prevent a second use, by 2020.
HIV Likely Evolved to Enter Latent State Because This Fuels Survival
A pair of new studies suggest that HIV evolved to enter into a latent state in order to thrive in the long run, and that the virus itself, and not infected immune cells, controls when replication stops and starts.
More Evidence That Circumcision Is Lowering African HIV Rates
The expansion of male circumcision in Rakai, Uganda, is substantially reducing the rate of new cases of HIV among men in the district.
U.S. Fails in Abstinence and Faithfulness Push in Sub-Saharan Africa
The nearly $1.3 billion the U.S. government has spent promoting abstinence and faithfulness in sub-Saharan Africa has gone to waste,
More Treatment News

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.

Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ



Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Do you ever have problems sleeping?
Yes
No

Survey
Lean On Me

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2015 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.